EricKoMD

PubMed

• Narrative review of stereotactic body radiation therapy combined with tyrosine kinase inhibitors for oligometastatic-mutated non-small cell lung cancer: present and fu...
  Xinchen Zhao, Shengwei Zhang, Xiaoyue Sun, Yao Lin, Luca Capone
  Translational Lung Cancer Research. 2024-06-30
• Immunotherapy for head and neck cancer: where do we go from here?
  Eric C Ko, Glenn J Hanna
  Immunotherapy. 2023-12-01
• 3 citations
  Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma.
  James L Shen, Kevin W O'Connor, Janaki Moni, Susan Zweizig, Thomas J Fitzgerald
  Advances in Radiation Oncology. 2022-10-25

Abstracts/Posters

• Adjusted risk stratification for Gleason score (GS) 8 prostate cancer patients treated with trimodality therapy
  Liu JT, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
• The potential impact of medications on biochemical control following definitive management of prostate cancer
  Blacksburg SR, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
• Association of genetic factors with PSA response in prostate cancer patients receiving definitive radiotherapy
  Ko E, Kerns SL, Stone NN, Stock RG, Ostrer H, Rosenstein BS, ASTRO 2012, Boston, MA, USA
• Quality of life with adjuvant radiotherapy following transoral robotic surgery (TORS) for head and neck cancer
  Carpenter TJ, Gupta V, Buckstein MH, Ko EC, Posner MR, Genden EM, ASTRO 2012, Boston, MA, USA
• PSA nadir of <0.5ng/ml following brachytherapy for early stage prostate adenocarcinoma predicts for freedom from PSA failure and distant metastasis
  Ko EC, Stone NN, Stock RG, ASTRO 2010, San Diego, CA, USA
• Early PSA failure time following brachytherapy predicts for decreased prostate-specific and overall survival
  Ko EC, Stone NN, Stock RG, ASTRO 2011, Miami Beach, FL, USA
• Join now to see all